BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36915194)

  • 1. Eukaryotic Initiation Factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity.
    Martínez-Férriz A; Gandía C; Pardo-Sánchez JM; Fathinajafabadi A; Ferrando A; Farràs R
    Cell Commun Signal; 2023 Mar; 21(1):54. PubMed ID: 36915194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic role of eIF-5A2 in the development of ovarian cancer.
    Guan XY; Fung JM; Ma NF; Lau SH; Tai LS; Xie D; Zhang Y; Hu L; Wu QL; Fang Y; Sham JS
    Cancer Res; 2004 Jun; 64(12):4197-200. PubMed ID: 15205331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of two novel Trichomonas vaginalis eif-5a genes.
    Carvajal-Gamez B; Arroyo R; Lira R; López-Camarillo C; Alvarez-Sánchez ME
    Infect Genet Evol; 2010 Mar; 10(2):284-91. PubMed ID: 20060503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EIF5A2 is a novel chemoresistance gene in breast cancer.
    Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
    Breast Cancer; 2015 Nov; 22(6):602-7. PubMed ID: 24638963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of genes encoding the hypusine-containing translation initiation factor, eIF-5A, in tobacco.
    Chamot D; Kuhlemeier C
    Nucleic Acids Res; 1992 Feb; 20(4):665-9. PubMed ID: 1542563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of inhibitors of RNA and protein synthesis on the subcellular distribution of the eukaryotic translation initiation factor, eIF-5A, and the HIV-1 Rev protein.
    Shi XP; Yin KC; Waxman L
    Biol Signals; 1997; 6(3):143-9. PubMed ID: 9285097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking Modification of Eukaryotic Initiation 5A2 Antagonizes Cervical Carcinoma via Inhibition of RhoA/ROCK Signal Transduction Pathway.
    Liu X; Chen D; Liu J; Chu Z; Liu D
    Technol Cancer Res Treat; 2017 Oct; 16(5):630-638. PubMed ID: 27609633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation.
    Park MH; Wolff EC; Folk JE
    Biofactors; 1993 May; 4(2):95-104. PubMed ID: 8347280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma.
    Xie D; Ma NF; Pan ZZ; Wu HX; Liu YD; Wu GQ; Kung HF; Guan XY
    Hum Pathol; 2008 Jan; 39(1):80-6. PubMed ID: 17949776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of eIF-5A2 in mice causes accelerated organismal aging by increasing chromosome instability.
    Chen M; Huang JD; Deng HK; Dong S; Deng W; Tsang SL; Huen MS; Chen L; Zan T; Zhu GX; Guan XY
    BMC Cancer; 2011 May; 11():199. PubMed ID: 21612665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological Relevance and Therapeutic Potential of the Hypusine Modification System.
    Pällmann N; Braig M; Sievert H; Preukschas M; Hermans-Borgmeyer I; Schweizer M; Nagel CH; Neumann M; Wild P; Haralambieva E; Hagel C; Bokemeyer C; Hauber J; Balabanov S
    J Biol Chem; 2015 Jul; 290(30):18343-60. PubMed ID: 26037925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder.
    Luo JH; Hua WF; Rao HL; Liao YJ; Kung HF; Zeng YX; Guan XY; Chen W; Xie D
    Cancer Sci; 2009 May; 100(5):896-902. PubMed ID: 19298601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer.
    Guan XY; Sham JS; Tang TC; Fang Y; Huo KK; Yang JM
    Cancer Res; 2001 May; 61(9):3806-9. PubMed ID: 11325856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation initiation factor eIF-5A, the hypusine-containing protein, is phosphorylated on serine in Saccharomyces cerevisiae.
    Kang HA; Schwelberger HG; Hershey JW
    J Biol Chem; 1993 Jul; 268(20):14750-6. PubMed ID: 8325852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy.
    Chen W; Luo JH; Hua WF; Zhou FJ; Lin MC; Kung HF; Zeng YX; Guan XY; Xie D
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):400-8. PubMed ID: 19155439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.
    Yang GF; Xie D; Liu JH; Luo JH; Li LJ; Hua WF; Wu HM; Kung HF; Zeng YX; Guan XY
    Gynecol Oncol; 2009 Feb; 112(2):314-8. PubMed ID: 19054548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular localization of the hypusine-containing eukaryotic initiation factor 5A by immunofluorescent staining and green fluorescent protein tagging.
    Jao DL; Yu Chen K
    J Cell Biochem; 2002; 86(3):590-600. PubMed ID: 12210765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of eukaryotic translation initiation factors 4E and 2alpha is increased frequently in bronchioloalveolar but not in squamous cell carcinomas of the lung.
    Rosenwald IB; Hutzler MJ; Wang S; Savas L; Fraire AE
    Cancer; 2001 Oct; 92(8):2164-71. PubMed ID: 11596034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae.
    Kang HA; Hershey JW
    J Biol Chem; 1994 Feb; 269(6):3934-40. PubMed ID: 8307948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translation initiation factor 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae.
    Schnier J; Schwelberger HG; Smit-McBride Z; Kang HA; Hershey JW
    Mol Cell Biol; 1991 Jun; 11(6):3105-14. PubMed ID: 1903841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.